Strikingly, Black patients with ER + /HER2- and HER2+ breast cancer had significantly higher TMEM doorway score and macrophage density than White ER + /HER2- and HER2+ patients, a difference not observed in TNBC. The gene discussed is ESR1; the disease is breast carcinoma.